BR100 Increased By (0.55%)
BR30 Increased By (0.73%)
KSE100 Increased By (0.33%)
KSE30 Increased By (0.37%)
AGHA 7.47 Decreased By ▼ -0.09 (-1.19%)
BECO 5.14 Increased By ▲ 0.05 (0.98%)
BML 55.00 Increased By ▲ 0.02 (0.04%)
BOP 32.80 Decreased By ▼ -0.18 (-0.55%)
CNERGY 10.37 Increased By ▲ 0.27 (2.67%)
CSIL 5.10 Decreased By ▼ -0.03 (-0.58%)
FCCL 52.31 Increased By ▲ 1.06 (2.07%)
FFL 16.52 Increased By ▲ 0.34 (2.1%)
FNEL 1.22 Increased By ▲ 0.03 (2.52%)
KEL 7.22 Increased By ▲ 0.16 (2.27%)
KOSM 5.84 Increased By ▲ 0.30 (5.42%)
LOTCHEM 27.18 Decreased By ▼ -1.94 (-6.66%)
MLCF 90.30 Increased By ▲ 1.48 (1.67%)
NBP 196.85 Decreased By ▼ -0.64 (-0.32%)
NCPL 55.55 Increased By ▲ 0.53 (0.96%)
NPL 65.20 Increased By ▲ 0.32 (0.49%)
OGDC 313.90 Increased By ▲ 1.95 (0.63%)
PACE 10.44 Increased By ▲ 0.23 (2.25%)
PAEL 41.24 Increased By ▲ 0.25 (0.61%)
PIBTL 16.14 Increased By ▲ 0.18 (1.13%)
PPL 213.99 Increased By ▲ 1.33 (0.63%)
PRL 54.10 Increased By ▲ 1.56 (2.97%)
PTC 70.00 Increased By ▲ 0.92 (1.33%)
SSGC 25.27 Increased By ▲ 0.17 (0.68%)
TBL 9.65 Increased By ▲ 0.03 (0.31%)
TELE 8.37 Increased By ▲ 0.05 (0.6%)
TPL 18.20 Increased By ▲ 0.45 (2.54%)
TPLP 13.14 Decreased By ▼ -0.08 (-0.61%)
TREET 21.45 Decreased By ▼ -0.29 (-1.33%)
TRG 59.89 Increased By ▲ 3.00 (5.27%)
Pakistan

Novartis donates RS41.25mn to PRCS for the fight against COVID-19 pandemic

Novartis Pakistan will be working with PRCS to distribute the Testing Kits and PPEs to Health Care staff in areas m
Published Updated
  • Novartis Pakistan will be working with PRCS to distribute the Testing Kits and PPEs to Health Care staff in areas most severely affected across all provinces.

Novartis donated PKR 41.25 Million to Pakistan Red Crescent Society (PRCS), one of the largest humanitarian organizations in the country to support in efforts against COVID-19.

Novartis Pakistan will be working with PRCS to distribute the Testing Kits and PPEs to Health Care staff in areas most severely affected across all provinces.

Dr. Imran Rasheed, Chief Executive Officer, Novartis Pharma Pakistan, said, “Novartis Pakistan feels proud to stand with our Healthcare Professionals at their hour of need and hope to mitigate and contain this deadly infection as soon as humanly possible. Novartis has always remained on the forefront when it comes to Corporate Social Responsibility.

In Pakistan, we have ongoing projects in collaboration with government, NGOs and other partners working actively for the benefits of patients. We have the biggest Oncology Access program in Pakistan, providing cancer medicines free of cost, worth billions of rupees. During this challenging time of COVID-19 Pandemic, with this donation, Novartis contributing back to the society is core to our strategy and one of the pillars of Novartis vision”.

Comments

Comments are closed for this article.